Global X S&P Biotech ETF
CURE
Global X S&P Biotech ETF CURE Strategy
The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
ETFs News & Analysis
etfs
Young & Invested: Are these the smartest type of ETFs?
Can this approach offer meaningful alpha generation?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,091.40 | 51.20 | 0.57% |
| CAC 40 | 7,694.20 | 25.51 | -0.33% |
| DAX 40 | 23,766.83 | 172.03 | 0.73% |
| Dow JONES (US) | 45,283.16 | 11.93 | 0.03% |
| FTSE 100 | 9,217.81 | 39.82 | 0.43% |
| HKSE | 25,058.51 | 284.92 | -1.12% |
| NASDAQ | 21,501.18 | 3.45 | 0.02% |
| Nikkei 225 | 42,580.27 | 641.38 | 1.53% |
| NZX 50 Index | 13,133.20 | 58.39 | 0.45% |
| S&P 500 | 6,453.13 | 4.87 | 0.08% |
| S&P/ASX 200 | 8,826.50 | 59.20 | 0.68% |
| SSE Composite Index | 3,765.88 | 47.68 | -1.25% |